|KDEV -- Sweden Stock|| |
SEK 8.86 0.42 4.53%
Dr. Hans Wigzell, M.D., Ph.D. was Chairman of the Board of Directors at Karolinska Development AB since December 29, 2017. He was Independent Director of the Company since 2006. He no longer serves as Independent Chairman of the Board effective as of September 30, 2013. He is also Chairman of Rhenman Partner Asset Management AB and Cadila Pharmaceuticals Sweden Aktieboag, and Member of the Boards of Sarepta Therapeutics Inc. and RaySearch Laboratories AB. He is Member of The Royal Swedish Academy of Engineering Sciences and of the Royal Swedish Academy of Sciences. His previous assignments include, among others, President of Karolinska Institutet Nobel Committee, and President of Karolinska Institutet and Director General of the Smittskyddsinstitutet. He is Professor Emeritus of Immunology and Medical Doctor.
Age: 79 Chairman Since 2017 Ph.D
46 8 52 48 60 70 http://www.karolinskadevelopment.com